Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.03 USD | +3.25% | +3.08% | +19.41% |
01:18pm | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.41% | 715M | |
+5.66% | 111B | |
+11.66% | 106B | |
-12.62% | 22.24B | |
+0.20% | 21.25B | |
-4.97% | 18.97B | |
-35.21% | 18.52B | |
-10.80% | 16.81B | |
+37.49% | 12.54B | |
-24.66% | 8.09B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Raymond James Initiates WAVE Life Sciences at Outperform Rating With $7 Price Target